Should You Buy SpaceX Stock on the Dip? Here's My Honest Take.

SpaceX has pulled back moderately from its post-IPO peak, but the article argues the decline does not change the company’s strong business fundamentals or growth outlook. Morningstar’s fair value estimate of $63 per share implies about an $830 billion market cap, roughly one-third of the stock’s current valuation, highlighting continued valuation concerns despite Starlink, launch dominance, and AI-related wins. The piece is effectively a cautionary take: the dip is not viewed as enough to make the stock attractive yet.

Analysis

The important read-through is not that one private-market darling is expensive; it is that public-market structure can overwhelm fundamentals when float is small, index demand is mechanical, and narrative ownership is concentrated. That creates a reflexive setup where price discovery lags business reality for months, especially when incremental supply is gated by lockups rather than by operating performance. In that regime, the first big drawdown often looks like a buying opportunity, but it is usually just the market re-testing where liquidity actually clears.

Second-order beneficiaries are the companies that monetize the same AI/launch/space narrative without the same valuation compression risk. Alphabet has a cleaner asymmetric setup because any incremental compute demand from frontier-model workloads is instantly monetizable without relying on future capital-raise optionality, while Nasdaq’s role as a market-structure gatekeeper makes it more exposed to the backlash if index inclusion is seen as amplifying distortions. Morningstar’s low fair-value anchor matters less as a point estimate than as a signal that fundamental models are still far below where momentum has cleared; that gap tends to narrow through time, not price.

The real catalyst to watch is insider supply. When lockups expire, you get the first true test of whether late-stage holders value liquidity over upside convexity; even modest selling can reset the marginal clearing price because there is no deep natural retail bid at these levels. If the stock is still elevated into that window, the risk/reward shifts from “expensive but unstoppable” to “crowded and mechanically supported,” which is when single-name downside can accelerate 20-30% in a few sessions.

Contrarian view: the market may be underpricing how long scarcity can trump fundamentals if the stock is admitted to more passive and quasi-passive vehicles. In that case, a dip can remain a dip for quarters, not days. But the cleaner expression is not to short the story outright; it is to express skepticism through relative value against firms with real monetization today and less narrative beta.

Key Decisions for Investors

• Do not initiate a fresh long in SPCX at current levels; wait for the post-lockup supply window and only consider entry if the stock reprices at least 25-35% lower, where the margin of safety begins to compensate for supply risk.
• Pair trade: long GOOGL vs short SPCX for the next 3-6 months. Rationale: GOOGL captures AI demand with existing cash flows and lower valuation dispersion, while SPCX carries the highest downside to a liquidity reset; target 1.5x gross on the long leg against 1.0x on the short leg.
• Buy NDAQ on any pullback of 5-8% as a market-structure hedge. If index-concentration concerns rise, NDAQ can benefit from higher listings/volatility/turnover even as enthusiasm around a flagship new listing fades.
• Use MORN as a small tactical long only if you want exposure to valuation skepticism becoming institutionalized. The trade works if the market starts rewarding independent appraisal over momentum; downside is limited, but upside should be treated as a mean-reversion trade over 1-2 quarters.
• If you must express a bearish view on SPCX, prefer put spreads 2-4 months out rather than outright shorting. That captures the highest probability event—the lockup overhang—while limiting damage if passive inflows keep the stock elevated longer than expected.